Interventions to prevent or reduce the level of frailty in community-dwelling older adults: a scoping review of the literature and international policies

…, AP Ayala, A Roy, M Rodríguez Monforte… - Age and …, 2017 - academic.oup.com
Background frailty impacts older adults’ ability to recover from an acute illness, injuries and
other stresses. Currently, a systematic synthesis of available interventions to prevent or …

Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature

…, P Noto, J Vecchiet, ADA Monforte… - JAIDS Journal of …, 2002 - journals.lww.com
Knowledge of factors associated with medication adherence could help HIV clinicians to target
persons in need of intervention, design these interventions, and help researchers to plan …

Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing

E Girardi, CA Sabin, AA Monforte - JAIDS Journal of Acquired …, 2007 - journals.lww.com
A substantial proportion of HIV-infected individuals do not present for HIV testing until late in
infection; these individuals are often ill, have a high mortality risk, and are less likely to …

[HTML][HTML] Compassionate use of remdesivir for patients with severe Covid-19

…, J Cunningham, A D'Arminio Monforte… - … England Journal of …, 2020 - Mass Medical Soc
Background Remdesivir, a nucleotide analogue prodrug that inhibits viral RNA polymerases,
has shown in vitro activity against SARS-CoV-2. Methods We provided remdesivir on a …

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

…, B Ledergerber, F Dabis, D Costagliola, ADA Monforte… - The Lancet, 2002 - thelancet.com
Background Insufficient data are available from single cohort studies to allow estimation of
the prognosis of HIV-1 infected, treatment-naive patients who start highly active antiretroviral …

Changing patterns of mortality across Europe in patients infected with HIV-1

…, A Chiesi, V Miller, P Gargalianos, AA Monforte… - The Lancet, 1998 - thelancet.com
Background The introduction of combination antiretroviral therapy and protease inhibitors has
led to reports of falling mortality rates among people infected with HIV-1. We examined the …

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

…, C Katlama, O Kirk, P Reiss, AA Monforte… - The Lancet, 2003 - thelancet.com
Background Since the introduction of highly active antiretroviral therapy (HAART), little is
known about whether changes in HIV-1 mortality and morbidity rates have been sustained. We …

Cardiovascular disease risk factors in HIV patients–association with antiretroviral therapy. Results from the DAD study

…, R Weber, P Reiss, R Thiébaut, O Kirk, AA Monforte… - Aids, 2003 - journals.lww.com
Objective: To determine the prevalence of risk factors for cardiovascular disease (CVD) among
HIV-infected persons, and to investigate any association between such risk factors, stage …

[BOOK][B] Geometric, control and numerical aspects of nonholonomic systems

JC Monforte - 2002 - books.google.com
Nonholonomic systems are a widespread topic in several scientific and commercial domains,
including robotics, locomotion and space exploration. This work sheds new light on this …

Trends in underlying causes of death in people with HIV from 1999 to 2011 (D: A: D): a multicohort collaboration

…, M Law, W el Sadr, O Kirk, N Friis-Moller, AA Monforte… - The Lancet, 2014 - thelancet.com
Background With the advent of effective antiretroviral treatment, the life expectancy for
people with HIV is now approaching that seen in the general population. Consequently, the …